CIRCULATING CELL-FREE DNA IS A BIOMARKER OF PREMATURE BIRTH AND COVID-19 AND PREDICTS PRENATAL CEREBRAL ISCHEMIA IN NEWBORNS

Authors:

Abstract:

Circulating cell-free DNA is a possible marker of not only apoptosis, but also COVID-19 in pregnant, which can also be a trigger factor for premature birth and predicts prenatal hypoxic-ischemic encephalopathy injury in newborns. DNA fragmentation in tissues and blood plasma was measured with the diphenylamine assay. The material for the study was the peripheral blood from pregnant women and newborns, cord blood, tissue of the placenta. A comparison of the level of cfDNA in the serum of healthy pregnant and pregnant women with premature birth suggests a high level of it in women with premature birth. Pregnant women with COVID-19 had significantly higher cfDNA values as compared to those in healthy pregnant women in cord blood, placenta and in newborns from women with COVID-19. The level of cfDNA increased with the severity of neonatal hypoxic-ischemic encephalopathy injury in newborns from women with premature birth.

Keywords:

cfDNA preterm birth COVID-19 prenatal hypoxic-ischemic encephalopathy

References:

1. Akhtar H, Patel C, Abuelgasim E, Harky A. COVID-19 (SARS-CoV-2) Infection in Pregnancy: A Systematic Review. Gynecol Obstet Invest. 2020;85(4):295-306. doi:10.1159/000509290.
2. Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R. et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012; 379:2162–2172. doi: (10.1016/S0140-6736(12)60820-4).
3. Boekel SR,Davidson DJ, Norman JE, Stock SJ. Cell-free fetal DNA and spontaneous preterm birth. 2018;155(3):R137–R145.
4. Bourgonje AR, Abdulle AE, Angiotensin-converting enzyme 2 (ACE2). SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19). J Pathol.2020;251:228–248. doi: 10.1002/path.547.
5. Chen H, Guo J, Wang C. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395:809– 815.
6. Chin PY, Dorian CL, Hutchinson MR. Novel Toll-like receptor-4 antagonist (+)-naloxone protects mice from inflammation-induced preterm birth. 2016;6:36112.
7. Crigna AT, Samec M, Koklesova L. Cell-free nucleic acid patterns in disease prediction and monitoring—hype or hope? EPMA J. 2020;11(4):603-627. doi:10.1007/s13167-020-00226-x.
8. Gomez-Lopez N, Romero R, Schwenkel G. Cell-Free Fetal DNA Increases Prior to Labor at Term and in a Subset of Preterm Births. Reprod Sci. 2020;27(1):218-232. doi:10.1007/s43032-019-00023-6.
9. Hedermann G, Hedley PL, Baekvad-Hansen M. Danish premature birth rates during the COVID-19 lockdown. Arch Dis Child Fetal Neonatal Ed. 2021;106(1):93-95. doi:10.1136/archdischild-2020-319990.
10. Khalil A, von Dadelszen P, Draycott T, Ugwumadu A, O’Brien P, Magee L. Change in the incidence of stillbirth and preterm delivery during the COVID-19 pandemic. JAMA. 2020;324(7):705-706. doi:10.1001/jama.2020.12746.
11. Liu L, Oza S, Hogan D. Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the sustainable development goals. Lancet. 2016;388:3027–35. doi: 10.1016/S0140-6736(16)31593-8.
12. Noda T, Iwakiri R, Fujimoto K. Programmed cell death induced by ischemia-reperfusion in rat intestinal mucosa. AJP. 1998;274(2):G270-G276.
13. Philip RK, Purtill H, Reidy E. Unprecedented reduction in births of very low birthweight (VLBW) and extremely low birthweight (ELBW) infants during the COVID-19 lockdown in Ireland: a ‘natural experiment’ allowing analysis of data from the prior two decades. BMJ Glob Health. 2020;5(9):e003075. doi:10.1136/bmjgh-2020-003075.
14. Pryimenko NO, Kotelevska TM, Dubynska HM, Kaidashev IP, Pikul KV. Single nucleotide polymorphisms of TLR-2, TLR-3, TLR-4 and susceptibility to inflammatory diseases of the respiratory tract. Zaporozhye medical journal. 2018;20(5):640–645. doi: 10.14739/2310-1210. 2018.5.141527.

Publication:

«World of Medicine and Biology» Vol. 18 No. 79 (2022) , с. 79-84
УДК 616.61-006:616.65+576.367

DOI:

https://doi.org/10.26724/2079-8334-2022-1-79-79-84